Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu

Monica Javidnia, Ph.D.

Contact Information

Faculty Appointments

Biography

Research

My primary research projects are
1. Relating symptomatic treatments to Parkinson’s disease patient outcomes and self-reported symptom burden
2. Using digital tools (e.g., smartphone applications, sensors) to measure drug pharmacodynamics, disease progression, and clinically-meaningful outcomes/events (e.g., time to treatment, falls, cognitive impairment)

Credentials

Education

2011
BS | University of Texas at Dallas
Neuroscience

2012
MS | University of Texas at Dallas
Applied Cognition and Neuroscience

2017
PhD | Georgetown University
Pharmacology

Post-doctoral Training & Residency

2017 - 2020
University of Rochester Medical Center

Awards

2019 - 2020
TEDMED Research Scholar

Publications

Journal Articles

5/15/2020
Javidnia M, Shoulson I, Kieburtz K, Venuto C. "Pharmacotherapy Use for Non-Motor Symptoms Among de novo Parkinson's Disease Parkinson's Progression Markers Initiative Participants." Journal of Parkinson's disease.. 2020 May 15; Epub 2020 May 15.

1/1/2020
Javidnia M, Frasier M, Shoulson I, Turkoz I, Budur K. "Innovative Approaches for Slowing Disease Progression in Parkinson's Disease: Takeaways from the 14th Annual International Society for Central Nervous System Clinical Trials and Methodology Scientific Meeting." . 2020 Jan 1; 17(1-3):14-19.

2019
Merchant KM, Cedarbaum JM, Brundin P, Dave KD, Eberling J, Espay AJ, Hutten SJ, Javidnia M, Luthman J, Maetzler W, Menalled L, Reimer AN, Stoessl AJ, Weiner DM, . "A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein." Journal of Parkinson's disease.. 2019 9(1):31-61.

VIEW ALL PUBLICATIONS